Amgen's cancer drug combo cut death risk by 58% in lung cancer trial Oct 26, 2026 · Cris Tolomia Median survival reached 21.1 months with Imdelltra plus AstraZeneca's Imfinzi, versus 12.7 months for Imfinzi alone Read more »